In the biotech space, big announcements often precede big share price movements; both were on tap for Entera Bio (ENTX) on Wednesday.
Entera shares took off after the company provided an update from the placebo-controlled, double blind Phase 2 trial of…
Entera Bio Stock Could More Than Double From Here, Says Analyst
Share this article
More News

3 Top Cryptocurrencies Down 67% or More Worth Buying Right Now
September 21, 2026

Vietnam, Austria Focus On Crypto Oversight Ties Ahead Of 2026 Licenses
September 21, 2026




US Sanctions BitBank and Developer Over Alleged IRGC Crypto Transfers
September 20, 2026
